NEW YORK (GenomeWeb News) – Simulations Plus has sold a five-year license for the newest version of its ClassPharmer software to the National Institute of Health Sciences in Japan, the company said today.
 
Japan’s NIHS will use ClassPharmer to help generate chemically relevant compound classifications, Simulations Plus said. The organization had been using an earlier version of ClassPharmer, previously sold by Bioreason, which Simulations Plus acquired last year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.